Simple Drug Regimen Reduces Recurrence of Metastatic Cancer: Study

A surgeon team uses a Loop-X live medical imagery system to secure the work on the spine of a patient affected by a metastatic breast cancer at the University-affiliated hospital (CHU) in Angers, France, on June 10, 2021. AFP via Getty Images/Loic Venance

A simple drug regimen to diminish stress and inflammation reduced the risk of developing metastases after surgery to remove cancerous tumors, according to a recent study.

The study found that 5 years after surgery, nine of the 18 patients who received a placebo (50 percent) developed metastatic cancer, compared with only two of the 16 patients (12.5 percent) who received the drug regimen.